VISTAGEN THERAPEUTICS, INC. Treasury Stock, Value
VISTAGEN THERAPEUTICS, INC. (VTGN) had Treasury Stock, Value of $3.97 million as of 2022-12-31, per its 10-Q filed 2023-02-07.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:TreasuryStockValue · last filed 2023-02-07
- 2022-12-31: Treasury Stock, Value $3.97M.
- 2022-09-30: Treasury Stock, Value $3.97M.
- 2022-06-30: Treasury Stock, Value $3.97M.
- 2022-03-31: Treasury Stock, Value $3.97M.
| Period end | Treasury Stock, Value | Treasury Stock, Value as first filed |
|---|---|---|
| 2022-12-31 | $3.97M 10-Q · filed 2023-02-07 | |
| 2022-09-30 | $3.97M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $3.97M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $3.97M 10-Q · filed 2023-02-07 | |
| 2021-12-31 | $3.97M 10-Q · filed 2022-02-10 | |
| 2021-09-30 | $3.97M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $3.97M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $3.97M 10-K · filed 2022-06-23 | |
| 2020-12-31 | $3.97M 10-Q · filed 2021-02-11 | |
| 2020-09-30 | $3.97M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $3.97M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $3.97M 10-K · filed 2021-06-29 | |
| 2019-12-31 | $3.97M 10-Q · filed 2020-02-13 | |
| 2019-09-30 | $3.97M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $3.97M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $3.97M 10-K · filed 2020-06-29 | |
| 2018-12-31 | $3.97M 10-Q · filed 2019-02-12 | |
| 2018-09-30 | $3.97M 10-Q · filed 2018-10-29 | |
| 2018-06-30 | $3.97M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $3.97M 10-K · filed 2019-06-25 | |
| 2017-12-31 | $3.97M 10-Q · filed 2018-02-12 | |
| 2017-09-30 | $3.97M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $3.97M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $3.97M 10-K · filed 2018-06-26 | |
| 2016-12-31 | $3.97M 10-Q · filed 2017-02-13 | |
| 2016-09-30 | $3.97M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $3.97M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $3.97M 10-K · filed 2017-06-29 | |
| 2015-12-31 | $3.97M 10-Q · filed 2016-02-16 | |
| 2015-09-30 | -$3.97M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $3.97M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $3.97M 10-K · filed 2016-06-24 | |
| 2014-12-31 | $3.97M 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $3.97M 10-Q · filed 2014-11-19 | |
| 2014-06-30 | $3.97M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $3.97M 10-K · filed 2015-06-29 | |
| 2013-12-31 | -$3.97M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $3.97M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $3.97M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $3.97M 10-Q · filed 2014-11-19 | -$3.97M 10-Q · filed 2014-02-14 |
| 2012-12-31 | -$3.97M 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $3.97M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $3.23M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $3.97M 10-Q · filed 2013-11-14 | $3.23M 10-K · filed 2012-07-02 |
| 2011-12-31 | $3.23M 10-Q · filed 2012-02-14 | |
| 2011-03-31 | $0.00 10-Q · filed 2012-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |